Výsledky vyhledávání - "David H. Regan"

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

Autor: Mark U. Rarick, Julia Bohlius, Alan E. Lichtin, Mark R. Somerfield, David Cella, David H. Regan, Charles L. Bennett, Jerome Seidenfeld, Karen L. Hagerty, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, J. Douglas Rizzo

Publikováno v: Journal of Clinical Oncology. 26:132-149

Purpose To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was expanded to address use of darbepoetin and thromboembolic risk associated with these agent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9711b50f9d641336ec7d430c4391d1
https://doi.org/10.1200/jco.2007.14.3396

Zobrazit plný text záznamu

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

Autor: Gary E. Raskob, Jeffrey S. Wasser, Indira Warrier, Alan E. Lichtin, JA Okerbloom, Louis M. Aledort, Victor S. Blanchette, James B. Bussel, John G. Kelton, David H. Regan, Douglas B. Cines, James N. George, P. J. Ballem, Robert McMillan, Steven H. Woolf

Publikováno v: Blood. 88:3-40

DIOPATHIC thrombocytopenic purpura (ITP, also I known as primary immune thrombocytopenic purpura) is a hematologic disorder for which appropriate diagnostic and treatment strategies are uncertain. In 1994, the American Society of Hematology (ASH) est

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::569d68d4ce2862a871029898914f19c5
https://doi.org/10.1182/blood.v88.1.3.bloodjournal8813

Zobrazit plný text záznamu

Effects of behavioral stimuli on plasma interleukin-1 activity in humans at rest

Autor: Steven H. Heffeneider, David H. Regan, Sharon McCoy, William H. Keppel, Fred L. Ramsey

Publikováno v: Journal of Clinical Psychology. 49:777-789

Interleukin-1 (IL-1) bioassays were done on 208 serum samples drawn from 7 volunteers, over several hours at 5-minute intervals, before, during, and after a relaxation-related behavioral stimulus. Individuals showed up to a 267% increase (t[29] = 7.7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e2f000c254b323ca00f0a6ac41450ae2
https://doi.org/10.1002/1097-4679(199311)49:6<777::aid-jclp2270490605>3.0.co

Zobrazit plný text záznamu

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

Autor: J. Douglas Rizzo, Matthew J. Goode, David H. Regan, Jerome Seidenfeld, Charles L. Bennett, Jerry L. Spivak, Melissa C. Brouwers, Darren Evanchuk, Mark R. Somerfield, Ann A. Jakubowski, Julia Bohlius, Patricia Hurley, Murat O. Arcasoy

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(33)

Purpose To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. Methods An Update Committee reviewed data published between January 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb4a02eb71c1fb2135d299f47f21a4d
https://pubmed.ncbi.nlm.nih.gov/20975064

Zobrazit plný text záznamu

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

Autor: Mark R. Somerfield, Charles L. Bennett, Julia Bohlius, Ann A. Jakubowski, David Cella, Benjamin Djulbegovic, Karen L. Hagerty, Jerome Seidenfeld, David H. Regan, Mark U. Rarick, Matthew J. Goode, Alan E. Lichtin, J. Douglas Rizzo

Publikováno v: Blood. 111(1)

Purpose: To update the American Society of Clinical Oncology/American Society of Hematology (ASCO/ASH) recommendations for the use of epoetin. The guideline was expanded to address use of darbepoetin and thromboembolic risk associated with these agen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629ef299e65590eda107a9b475d95ac9
https://pubmed.ncbi.nlm.nih.gov/17954703

Zobrazit plný text záznamu

Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer

Autor: Tammy Roque, Edward Agura, Mary Lange, Douglas Orr, Pankaj Khandelwal, Robert G. Mennel, Kristi J. McIntyre, Michael W. Schuster, Leslie Garrison, Robert Kirby, Lewis Duncan, Stephen E. Jones, Nikolay V. Dimitrov, William J. Hyman, David H. Regan

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(10)

PURPOSE: To measure the effect of PIXY321 (granulocyte-macrophage colony-stimulating factor/interleukin-3 S. cerevisiae fusion protein) on the incidence, duration, and complications of neutropenia and thrombocytopenia after moderate-dose fluorouracil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9efabab332911c3d809451e762b7b9a1
https://pubmed.ncbi.nlm.nih.gov/10506596

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání